Refoxy Pharmaceuticals

Healthcare & Life Sciences

Recent Finacing

Seed

Recent Raise

$9.6M

Refoxy Pharmaceuticals is a biotech company developing small molecule activators of the FOXO3 transcription factor to treat age-related diseases, with an initial focus on idiopathic pulmonary fibrosis.

Total Funding

$9.6M

Headquarters

Berlin, Germany

Founded

N/A

Website

refoxy.com

Focus Areas

Preclinical

Biotech

Small Molecule

FOXO3

Age-related Diseases

Therapeutic Pipeline

Investors

$High-Tech Gr\u00fcnderfonds logo$